MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns

18d ago, source: Yahoo Finance

Given the large stake in the stock by institutions, MannKind's stock price might ... opportunities in a stock Every investor in MannKind Corporation (NASDAQ:MNKD) should be aware of the most ...

MannKind Corporation (MNKD)

3d ago, source: Yahoo Finance

and WESTLAKE VILLAGE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled thera Key Insights Given ...

Danbury-based biopharmaceutical firm MannKind names new CFO

22d ago, source: Hartford Business

MannKind Corp., a Danbury-based company that develops inhaled therapeutic products, has named a new chief financial officer. The company said Tuesday that current CFO Steven B. Binder will retire ...

MannKind Corp MNKD

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

May 10th Options Now Available For MannKind (MNKD)

21d ago, source: Nasdaq

Investors in MannKind Corp (Symbol: MNKD) saw new options begin trading today, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options ...

MannKind Repays Certain Debt Obligations

16d ago, source: Business Insider

and WESTLAKE VILLAGE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and ...

MannKind Announces CFO Transition

23d ago, source: Stockhouse

and WESTLAKE VILLAGE, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and ...

MannKind Corporation

8d ago, source: TheStreet.com

MANNKIND CORP's gross profit margin for the fourth quarter of its fiscal year 2023 has significantly increased when compared to the same period a year ago. The company grew its sales and net ...

MannKind Corp.

22d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

MannKind Corp.

13d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...